Rani Therapeutics Holdings, Inc. (RANI)

RANI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	5.86	27.01	117.45	73.06	16.54
Short-Term Investments	42.68	71.48	0	0	0.25
Cash & Cash Equivalents	48.54	98.48	117.45	73.06	16.79
Cash Growth	-50.71%	-16.15%	60.77%	335.23%	-
Receivables	0	0	0	1.72	0
Other Current Assets	2.31	2.44	2.14	0.17	0.16
Total Current Assets	50.85	100.92	119.6	74.95	16.94
Property, Plant & Equipment	6.82	7.1	4.61	4.47	4.45
Long-Term Investments	0	0	0	0	1.63
Other Long-Term Assets	0.25	0	0	0	0
Total Long-Term Assets	7.07	7.1	4.61	4.47	6.08
Total Assets	57.92	108.03	124.21	79.42	23.02
Accounts Payable	0.65	1.46	1.21	0.68	2.12
Deferred Revenue	0	0	0	2.72	0.18
Current Debt	5.62	1.01	0	1.36	0
Other Current Liabilities	1.73	2.35	1.43	0.55	1.2
Total Current Liabilities	7.99	4.82	2.64	5.31	3.5
Long-Term Debt	24.48	29.21	0	2.41	0
Other Long-Term Liabilities	0	0	0	0.32	0.66
Total Long-Term Liabilities	24.48	29.21	0	2.73	0.66
Total Liabilities	32.47	34.02	2.64	8.04	4.15
Total Debt	30.1	30.21	0	3.77	0
Debt Growth	-0.38%	-	-	-	-
Retained Earnings	-72.89	-38.92	-8.33	-114	-97.3
Comprehensive Income	-0.01	-0.07	0	0	0
Shareholders' Equity	12.87	36.86	47.41	-113.34	-96.64
Net Cash / Debt	18.44	68.27	117.45	69.29	16.79
Net Cash / Debt Growth	-72.99%	-41.88%	69.52%	312.77%	-
Net Cash Per Share	0.72	2.87	6.01	1.48	0.36
Working Capital	42.86	96.11	116.96	69.64	13.45
Book Value Per Share	0.50	1.55	2.43	-2.42	-2.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).